-
In this issue: Some women with DVT may stop warfarin after six months; Vytorin and cancer; preventing recurrent stroke; and FDA news.
-
Fetal fibronectin is now being used in many hospitals to separate out those with preterm contractions (PTCs) who are in true labor from those with contractions who are not (and, therefore, not requiring tocolytics or hospitalization).
-
The objective of this study was to examine and compare the clinical behavior and outcome of uterine carcinosarcoma relative to grade 3 endometrioid carcinoma.
-
The lift study (Long-Term Intervention on Fractures with Tibolone) was a randomized, placebo-controlled multicenter trial in 22 countries of tibolone, 1.25 mg, given daily over 3 years.
-
In This Issue: Guidelines for prediabetes from The American College of Endocrinology; statins for the prevention of dementia? Possible help for women suffering from sexual side effects while on antidepressants; government incentives for electronic prescribing; FDA Actions.
-
Often there are articles in the ultrasound literature that have diagnostic implications extending far past the ultrasound findings that were the centerpieces of these papers.
-
Cho and colleagues studied 47 women with ultrasound-proven adenomyosis over a 3-year time period.
-
These Israeli researchers assigned 44 women with overactive bladder alternately into 2 groups: one group receiving 3 months of pelvic floor rehabilitation, and the other receiving oxybutynin.
-
-
Two clinical trials compared rivaroxaban vs enoxaparin prophylactic treatment to prevent venous thromboembolism (VTE) after total hip or knee arthroplasty.